Disc Medicine to Participate in Upcoming Investor Conferences
Disc Medicine, Inc., a clinical-stage biopharmaceutical company focusing on novel treatments for serious hematologic diseases, announced its management will participate in two upcoming investor conferences, including the H.C. Wainwright BioConnect and Jefferies Global Healthcare conferences, presenting fireside chats webcasted live and available fo…